Group GBDNDC (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877–897

Article  Google Scholar 

Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 20(5):385–397

Article  PubMed  PubMed Central  Google Scholar 

Collaborators GBDN (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459–480

Article  Google Scholar 

Mukherjee S, Sakunthala A, Gadhe L, Poudyal M, Sawner AS, Kadu P, Maji SK (2023) Liquid-liquid Phase Separation of alpha-Synuclein: A New Mechanistic Insight for alpha-Synuclein Aggregation Associated with Parkinson’s Disease Pathogenesis. J Mol Biol 435(1):167713

Article  PubMed  Google Scholar 

Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24(10):R453-462

Article  PubMed  PubMed Central  Google Scholar 

Head E (2009) Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging. Neurochem Res 34(4):670–678

Article  PubMed  Google Scholar 

Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. J Parkinsons Dis 3(4):461–491

Article  PubMed  PubMed Central  Google Scholar 

Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson’s disease. Front Neuroanat 9:91

Article  PubMed  PubMed Central  Google Scholar 

Ferrer I, Martinez A, Blanco R, Dalfo E, Carmona M (2011) Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm (Vienna) 118(5):821–839

Article  PubMed  Google Scholar 

Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell 18(6):e13031

Article  PubMed  PubMed Central  Google Scholar 

Barodia SK, Creed RB, Goldberg MS (2017) Parkin and PINK1 functions in oxidative stress and neurodegeneration. Brain Res Bull 133:51–59

Article  PubMed  Google Scholar 

Xu S, Yang X, Qian Y, Xiao Q (2018) Parkinson’s disease-related DJ-1 modulates the expression of uncoupling protein 4 against oxidative stress. J Neurochem 145(4):312–322

Article  PubMed  Google Scholar 

Johnson SL, Iannucci J, Seeram NP, Grammas P (2020) Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson’s disease. Biochem Biophys Res Commun 527(2):532–538

Article  PubMed  Google Scholar 

Sola P, Krishnamurthy P, Chintamaneni PK, Pindiprolu S, Kumari M (2020) Novel drug delivery systems of beta2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opin Drug Deliv 17(8):1119–1132

Article  PubMed  Google Scholar 

Bento-Pereira C, Dinkova-Kostova AT (2021) Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson’s disease. Med Res Rev 41(2):785–802

Article  PubMed  Google Scholar 

Power JH, Blumbergs PC (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathol 117(1):63–73

Article  PubMed  Google Scholar 

McCoy MK, Cookson MR (2011) DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy 7(5):531–532

Article  PubMed  PubMed Central  Google Scholar 

Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N, Li M, Pappa A et al (2014) Antioxidant gene therapy against neuronal cell death. Pharmacol Ther 142(2):206–230

Article  PubMed  Google Scholar 

Li JQ, Tan L, Yu JT (2014) The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener 9:47

Article  PubMed  PubMed Central  Google Scholar 

Bartus RT, Herzog CD, Chu Y, Wilson A, Brown L, Siffert J, Johnson EM Jr, Olanow CW et al (2011) Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson’s disease and nonhuman primate brains. Mov Disord 26(1):27–36

Article  PubMed  Google Scholar 

Berry AL, Foltynie T (2011) Gene therapy: a viable therapeutic strategy for Parkinson’s disease? J Neurol 258(2):179–188

Article  PubMed  Google Scholar 

Lee J, Song K, Huh E, Oh MS, Kim YS (2018) Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara. Redox Biol 18:6–15

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Wang Y, Huang J, Hu B, Huang W (2022) Identification of Immune-Related Hub Genes in Parkinson’s Disease. Front Genet 13:914645

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Kiryu H (2023) Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic model. Sci Rep 13(1):6817

Article  PubMed  PubMed Central  Google Scholar 

Zhu LN, Chen D, He C (2024) Metabolomics comparison of metabolites and functional pathways in the SH-SY5Y cell model of Parkinson’s disease under PEMF exposure. Heliyon 10(4):e26540

Article  PubMed  PubMed Central  Google Scholar 

Li S, Xiao J, Huang C, Sun J (2023) Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysis. Sci Rep 13(1):657

Article  PubMed  PubMed Central  Google Scholar 

Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Prog Neurobiol 106–107:17–32

Article  PubMed  Google Scholar 

Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657–673

Article  PubMed  PubMed Central  Google Scholar 

Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97(10):2499–2574

Article  PubMed  PubMed Central  Google Scholar 

Sun J, Lin XM, Lu DH, Wang M, Li K, Li SR, Li ZQ, Zhu CJ et al (2023) Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons. J Clin Invest 133(10).

Xu XM, Lin H, Maple J, Bjorkblom B, Alves G, Larsen JP, Moller SG (2010) The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J Cell Sci 123(Pt 10):1644–1651

Article  PubMed  Google Scholar 

Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253(1–2):269–285

Article  PubMed  Google Scholar 

Kelly PJ, Morrow JD, Ning M, Koroshetz W, Lo EH, Terry E, Milne GL, Hubbard J et al (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39(1):100–104

Article  PubMed  Google Scholar 

Earls RH, Menees KB, Chung J, Gutekunst CA, Lee HJ, Hazim MG, Rada B, Wood LB et al (2020) NK cells clear alpha-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of alpha-synucleinopathy. Proc Natl Acad Sci U S A 117(3):1762–1771

Article  PubMed  PubMed Central  Google Scholar